A Retrospective Observational Study of Risk Factors for Denosumab-Related Osteonecrosis of the Jaw in Patients with Bone Metastases from Solid Cancers.

Cancers (Basel) · 2020 · PMC7281320 · PMID 32408510

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

might be significantno p-value reported

However, in our study, no patients were treated with angiogenesis inhibitors or tyrosine kinase inhibitors, which might be significant risk factors for ONJ development.

also in 2,435 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.